• About us
• Contact

Advertisement

Product › Details

CNS drug (neurological drug)

	Next higher product group	pharmaceutical

Record changed: 2024-11-30

Advertisement

More documents for CNS drug (neurological drug)

• [1] EQT AB. (12/11/24). "Press Release: EQT Life Sciences Leads Series B Extension in Noema Pharma, Raising Total Series B Financing to CHF 130 million"....
• [2] PTC Therapeutics, Inc.. (12/2/24). "Press Release: PTC Therapeutics Enters into a Global License and Collaboration Agreement with Novartis for PTC518 Huntington's Disease Program". Warren, NJ....
• [3] H. Lundbeck A/S. (11/18/24). "Press Release: Lundbeck Announces Expiration of Longboard Tender Offer and That All Tender Offer Conditions Are Fulfilled"....
• [4] H. Lundbeck A/S. (10/14/24). "Press Release: Lundbeck to Acquire Longboard Pharmaceuticals in a Strategic Deal, Significantly Enhancing Its Neuroscience Pipeline". Valby & La Jolla, CA....
• [5] a:head bio AG. (10/9/24). "Press Release: a:head Secures Pre-Series A Funding and Appoints Margarete Schramboeck and Madeline Lancaster to the Supervisory Board". Vienna....
• [6] Nxera Pharma Co., Ltd.. (9/2/24). "Press Release: Nxera Pharma to Receive US$35 Million from Neurocrine Biosciences upon Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568". Tokyo & Cambridge....
• [7] Vandria S.A.. (8/21/24). "Press Release: Hevolution Foundation and Dolby Family Ventures Join Vandria’s 2nd Series A Closing, Bringing the Total round to $30.7M (CHF 28.3M) to Progress the Mitophagy Inducer VNA-318 into CNS Clinical Development". Lausan...
• [8] Systasy Bioscience GmbH. (7/31/24). "Press Release: Systasy Bioscience Announces Collaboration Agreement with Ono Pharmaceutical". Munich....
• [9] Addex Therapeutics S.A.. (7/22/24). "Press Release: Addex’s Partner Discontinues ADX71149 Development in Epilepsy". Geneva....
• [10] Merz Therapeutics GmbH. (7/10/24). "Press Release: Merz Therapeutics Closes $185M Asset Purchase Agreement with Acorda Therapeutics". Frankfurt a. M.....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.